Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Jolene Brighten breaks down the emerging research and real-world clinical observations around GLP-1 receptor agonists and endometriosis , including what is currently known, what remains theoretical, and why this conversation may be one of the most important developments in womens health right now
This is not a hypothetical concern
Changes in blood pressure, lipids and 10-year cardiovascular risk score In SURMOUNT trials, systolic blood pressure (BP) decreased by 5.910.5 mmHg with tirzepatide compared to a reduction of 0.92.4 mmHg with placebo ( In a subset of 600 participants from SURMOUNT-1 study, 24-hour ambulatory BP was measured at baseline and at week 36 (mean baseline systolic BP was 124.6 mmHg and diastolic BP was 72.1 mmHg) [Citation53]
Diabetes Care 2023;46:24951.ArticlePubMedPMCPDF 45
US$ 29.92
US$ 25.71
US$ 22.29
US$ 27.70
US$ 29.31
